ORI Updates

Elisabeth (Lis) Handley, previously the Director of ORI, has accepted a new role as the Principal Deputy Assistant Secretary for Health (PDASH) in the Office of the Assistant Secretary for Health (OASH). Dr. Wanda Jones will remain Acting Director for ORI. 

To assist institutions with determining whether a significant issue or lead may be relevant while conducting a research misconduct proceeding, ORI has constructed several hypothetical case examples and included them in an informational document.

Recordings and slide decks from the May 6, 2021 and May 10, 2021 Notice of Funding Opportunity Technical Assistance Webinars are now available.

ORI has launched the ORI File Transfer System (ORI-FTS), a FedRAMP authorized, cloud-based system for secure file transfer. 

ORI has released two notice of funding opportunity announcements (NOFOs) for projects that advance the field of research integrity.

The Office of Research Integrity (ORI) is seeking a highly qualified candidate to manage activities related to assigned cases of alleged research misconduct in biomedical research studies. This position will be filled through an OASH Staff Fellow appointment (starting at a GS-11 level equivalent and up to a GS-13 level equivalent with a doctoral degree and relevant experience).

ORI’s FY2020 Annual Report has been updated and is now available for viewing and downloading.

ORI has released its FY 2020 Annual Report, which highlights activities over the past year regarding investigations of research misconduct, communications, ORI’s grant program, ORI research projects, and ORI’s compliance programs.

ORI’s Division of Investigative Oversight will be hiring a Health Scientist at the GS 13 level. A Bachelor's or graduate/higher level degree in an academic field related to the medical field, health sciences, or allied sciences is required

ORI found that Yibin Lin, Ph.D., former postdoctoral fellow, McGovern Medical School, UTHealth, engaged in research misconduct in research supported by U.S Public Health Service (PHS) funds, specifically National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).